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Meex RC, Schrauwen P, Hesselink MK. Modulation of myocellular fat
stores: lipid droplet dynamics in health and disease. Am J Physiol Regul Integr
Comp Physiol 297: R913–R924, 2009. First published August 19, 2009;
doi:10.1152/ajpregu.91053.2008.—Storage of fatty acids as triacylglycerol (TAG)
occurs in almost all mammalian tissues. Whereas adipose tissue is by far the largest
storage site of fatty acids as TAG, subcellular TAG-containing structures—referred to
as lipid droplets (LD)—are also present in other tissues. Until recently, LD were
considered inert storage sites of energy dense fats. Nowadays, however, LD are
increasingly considered dynamic functional organelles involved in many intracellular
processes like lipid metabolism, vesicle trafficking, and cell signaling. Next to TAG,
LD also contain other neutral lipids such as diacylglycerol. Furthermore, LD are coated
by a monolayer of phospholipids decorated with a variety of proteins regulating the
delicate balance between LD synthesis, growth, and degradation. Disturbances in
LD-coating proteins may result in disequilibrium of TAG synthesis and degradation,
giving rise to insulin-desensitizing lipid intermediates, especially in insulin-responsive
tissues like skeletal muscle. For a proper and detailed understanding, more information
on processes and players involved in LD synthesis and degradation is necessary. This,
however, is hampered by the fact that research on LD dynamics in (human) muscle is
still in its infancy. A rapidly expanding body of knowledge on LD dynamics originates
from studies in other tissues and other species. Here, we aim to review the involvement
of LD-coating proteins in LD formation and degradation (LD dynamics) and to
extrapolate this knowledge to human skeletal muscle and to explore the role of LD
dynamics in myocellular insulin sensitivity.
adipose triglyceride lipase; hormone-sensitive lipase; perilipin adipocyte differen-
tiation-related proteins; muscle
STORAGE OF FAT IN WHITE ADIPOSE tissue (WAT) is the most
widely studied form of triacylglycerol (TAG) storage. In peri-
ods of caloric excess, adipose tissue mass expands by increas-
ing TAG content. During starvation, hydrolysis of TAG results
in mobilization of fatty acids to meet the organism’s energy
requirement and TAG content in adipocytes declines. Stored
TAG, hence, represents a dynamic pool of fatty acids.
Whereas adipose tissue is by far the largest storage site of
fatty acids as TAG, almost all mammalian cell types have the
ability to store fatty acids as TAG in lipid droplets (LD),
so-called ectopic fat storage. The LD-coating phospholipid
monolayer is covered with phospholipids, cholesterol, and
proteins. Next to TAG, LD also contain other neutral lipids like
diacylglycerols (DAG), cholesteryl esters, retinyl esters, and
free cholesterol. Lipid droplets may range in size from 200 m
in diameter to microlipid bodies of only 50 nm in diameter,
depending on the cellular lipid load and cell type (92).
Nowadays, LD are considered dynamic functional or-
ganelles. Next to lipid metabolism, LD are also involved in
vesicle trafficking and cell signaling (16, 92). The physiolog-
ical role of lipid droplets varies with the subcellular localiza-
tion, the morphology, and the (sub)proteome of the droplet. In
adipocytes, the cytoplasm is almost entirely occupied by the
LD, whereas in tissues with a high lipolytic rate like cardiac
and skeletal muscle, numerous small LD are present. Size, and
possibly function, is sensitive to diet, disease, nutritional status,
and training status (92) and on the balance between LD
synthesis and LD degradation.
Abundant storage of TAG in LD in metabolically dy-
namic tissues like cardiac and skeletal muscle, as well as the
liver and pancreas, may interfere with subcellular processes
like insulin signaling. Thus, a strong positive correlation
between ectopic TAG storage, measured by 1H NMR spec-
troscopy as intramyocellular lipid content (IMCL), and
insulin resistance (57, 69, 101) has been reported in insulin-
resistant subjects. Interestingly, endurance training, an in-
sulin-sensitizing intervention, also coincides with increased
IMCL content (40). In fact, we have shown that an increase
in IMCL is a very early response to training (119). In
addition, it has been shown that a 4-mo-insulin sensitizing
intervention of combined weight loss and physical activity
significantly decreased LD size, without a decline in total
myocellular triacylglycerol content (49). It is, therefore,
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unlikely that the presence of LD per se impedes insulin
signaling. Rather, it has been hypothesized that intermedi-
ates in LD synthesis and degradation, such as DAG, cer-
amides, and fatty acyl CoA esters might be responsible (56,
104, 112, 122). The balance between LD synthesis and
degradation, here referred to as LD dynamics, partly deter-
mines the fraction of lipid-derived intermediates.
In adipocytes, the phospholipid monolayer coating the LD is
decorated with several proteins involved in lipid droplet dy-
namics referred to as PAT proteins. PAT proteins [perilipin,
ADRP (for adipocyte differentiation-related protein), and
TIP47 (for tail-interacting protein of 47 kDa)]. are character-
ized by a common N-terminal motif (PAT domain). Other
recently discovered proteins, like S3-12 and OXPAT, possess
a high-sequence homology with the PAT domain and are also
considered PAT proteins. Throughout this review, we will use
the term PAT proteins not only for perilipin, ADRP, and
TIP-47, but also for S3-12 and OXPAT.
To better understand the origin of insulin-desensitizing lipid
moieties in skeletal muscle, a detailed understanding of the
processes involved in LD formation and degradation is hence
warranted. To date, however, data on LD dynamics in (human)
muscle are still scarce. A rapidly expanding body of knowl-
edge on LD dynamics comes from studies in other tissues and
other species. Therefore, we aim to review the current prevail-
ing knowledge on the process of LD synthesis and degradation
and to extrapolate this knowledge to human skeletal muscle
and, where data allow, explore the putative involvement in
muscular insulin sensitivity.
Lipid Droplet Hydrolysis
Hydrolysis of TAG stored in LD, requires a tight interplay
between multiple lipases. Tight (co)regulation of two major
lipases hormone-sensitive lipase (HSL) and adipose triglycer-
ide lipase (ATGL) has been demonstrated in human adipose
tissue (61, 73, 81). It can be hypothesized that an imbalance
between HSL and ATGL activity affects the level of insulin-
desensitizing intermediates like DAG, not only in adipose
tissue but also in peripheral tissues like skeletal muscle.
HSL. Hormone sensitive lipase (HSL) is a cytosolic protein
with three isoforms of which one (the 84-kDa isoform) is
abundantly present in adipose tissue (141) and in lesser
amounts in cardiac and skeletal muscle (51, 67, 72, 123).
Phosphorylation of specific serine residues of HSL results in
activation of HSL and subsequent translocation from the cy-
tosol to the phospholipid monolayer covering the LD to exert
lipolytic activity (14, 23, 33). HSL has affinity to multiple
lipid-related substrates (reviewed in Ref. 52). Here, we will
focus on its affinity to TAG, DAG, and monoacylglycerol
(MAG).
Activation of HSL can occur via a hormonal route and—in
case of muscle—a contraction-mediated route. In the hormonal
route, binding of catecholamines increases cAMP levels,
thereby activating PKA. Subsequently, phosphorylation of
HSL activation sites (Ser-563, Ser-659, and Ser-660) occurs (2,
5, 72, 146). Adrenergic activation of HSL can be blunted by
insulin via activation of AKT/PKB and PDE3B, resulting in
degradation of cAMP, thereby interfering with adrenergic
activation of lipolysis (28, 78, 94, 149). Although hormonal
regulation of lipolysis in muscle is similar to adipose tissue
lipolysis, the contractile nature of muscle and the resultant
rapid fluctuations in energy requirement need additional routes
to control muscle lipolysis. Physical exercise enhances circu-
latory adrenalin levels and increases muscle AMPK activity.
Stimulation of muscle lipolysis by exercise-induced increases
in adrenalin can partly be blunted by AMPK-dependent phos-
phorylation of HSL at inactivating serine residues Ser-565 in
skeletal muscle (possibly to adjust lipolytic rate to exercise
intensity), this AMP-dependent inactivation is not reported in
adipose tissue (145–147). Increases in Ca2 in the sarcolemma,
which initiates muscle contraction, also results in activation of
PKC and its downstream target ERK and subsequent HSL
activation (30, 45). These effects jointly regulate fine-tuning of
exercise-induced activation of muscle lipolysis to fuel muscle
contraction during graded exercise, as well as during prolonged
exercise.
ATGL. For the past 30 years, HSL was considered the only
lipase involved in TAG degradation. Interestingly, in HSL
knockout mice, total adipose tissue mass did not change (100,
143), while hydrolysis of TAG was still possible, but DAG
levels were increased (48). This suggests that a lipase other
than HSL must be involved in TAG hydrolysis. This protein
has been identified and was named adipose triglyceride lipase
(ATGL) (162). Independent studies identified the same protein
at about the same time and called it iPLA2 (58) and desnutrin
(142). ATGL is well preserved across species, and homologues
have been reported in yeast [Tgl4 (7)], in plants [SUGAR-
DEPENDENT1 lipase (31)], and in Drosophila [Brummer
lipase (46)]. Here, we will use the term ATGL for this lipase.
ATGL mRNA is predominantly expressed in WAT and
brown adipose tissue (BAT), and to a lesser extent in cardiac
and skeletal muscle (47, 60, 63, 65, 142, 162). Cell studies
revealed PPAR-mediated control of ATGL gene expression
(65, 142). Both thiazolidinedione-based PPAR agonists and
nonthiazolidinedione-based PPAR agonists increased ATGL
mRNA and ATGL protein in 3T3-L1 adipocytes (64). Knock-
down of PPAR reduced ATGL mRNA and protein expression
in adipocytes (64). Treating mice with rosiglitazone increased
ATGL mRNA and protein content (64, 77, 121).
During fasting, a state in which PPAR is activated through
elevated free fatty-acid levels, ATGL mRNA and ATGL pro-
tein expression is upregulated (63, 142). Refeeding results in a
decreased transcription of ATGL in mice (63, 65). Decreases in
transcription of the ATGL gene after refeeding can be a direct
effect of reduced PPAR activity in adipose tissue; it can also
be mediated via insulin, transient hyperglycemia or reduced
FFA levels by insulin-mediated suppression of adipose tissue
lipolysis. Later studies revealed that transcriptional control of
the ATGL gene in adipose tissue is under control of insulin
rather than glucose (63, 65, 68). Thus, ATGL appears to be
under control of PPAR, as well as insulin.
In 3T3-L1 adipocytes and under basal conditions, the ma-
jority of ATGL protein was present in the cytoplasm, whereas
a distinct fraction of ATGL was tightly associated with LD
(162). ATGL hydrolyzes the first ester bond of TAG and is
likely to limit lipolysis in smooth muscle, cardiac muscle, and
possibly skeletal muscle (47, 48, 120). Although knock-down
of ATGL (or its homologue Brummer lipase in the case of
Drosophila) resulted in a decreased lipolysis and an increase in
LD size in Drosophila, 3T3-L1 cells and in HeLa cells (35, 46,
63, 124), adipose tissue mass in mice lacking ATGL was
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increased, but not massively. Rather, fat storage in nonadipose
tissue increased to supraphysiological levels in skeletal and
cardiac muscle (47, 120). At 12 wk of age, a striking 20-fold
rise in cardiac TAG content was observed. As a result of the
increase in TAG accumulation, cardiac function was severely
hampered, and the knockout of ATGL resulted in cardiac
failure and premature death (47). In humans, carriers of a
ATGL polymorphism, resulting in lower ATGL activity, pos-
sess excessive ectopic TAG accumulation along with myop-
athy (35).
Reduced TAG lipolysis in muscle of ATGL knockout mice
was paralleled by a decrease in fat oxidation and a concomitant
increase in glucose oxidation during fasting and an unantici-
pated increased glucose uptake (47, 54). Increased glucose
uptake by the muscle, despite excessive TAG storage, may
reflect substrate availability; in the absence of ATGL activity,
fatty acids cannot be released from the LD and can hence not
be used as an energy source. Thus glucose uptake and oxida-
tion must increase to meet the energy demand.
The relatively modest (2 fold) increase in adipose tissue
mass and liver fat in ATGL knockout mice (47), suggests that
in these tissues ATGL may not be the major TAG lipase. In
cardiac muscle and to a lesser extent in skeletal muscle,
however, TAG storage in ATGL knockout mice is more
pronounced, suggesting an important role for ATGL-based
lipolysis of TAG in muscle. Overexpression of ATGL in
3T3-L1 cells, COS-7 cells, and HeLa cells (46, 63, 124, 142),
as well as overexpression of the Brummer lipase (homologue
of human ATGL) in Drosophila (46, 63, 124 , 142), resulted in
increased TAG lipolysis and a concomitant decrease in LD
size. Unilateral overexpression of ATGL in skeletal muscle
increased oxidation of LD-derived fatty acids and increased
insulin-desensitizing lipid intermediates like DAG and cer-
amide (148), suggesting that increased ATGL activity was not
matched with increased HSL activity. Thus, disequilibrium
between ATGL and HSL activity may increase DAG content
and impede insulin signaling.
In diet-induced obese C57BL/6J mice and ob/ob mice low
ATGL protein levels have been reported in muscle along with
high muscle TAG storage (65, 142, 148). In contrast to ATGL
protein levels, however, ATGL mRNA expression was higher
in skeletal muscle of C57BL/6J high-fat mice and ob/ob mice
compared with nonobese controls (148). Similar observations
have been made in subcutaneous adipose tissue of obese
subjects, in which low ATGL protein content was observed
along with high levels of ATGL mRNA (127), suggesting that
posttranscriptional processes profoundly affect ATGL protein
content. Despite the dissociation between mRNA expression
and protein content, the above-mentioned studies indicate an
association between myocellular ATGL and obesity. In adi-
pose tissue, however, diet-induced obesity in mice did not
affect ATGL protein content (64, 121), and ATGL mRNA
levels in ob/ob mice were comparable to lean littermates (71).
Similarly, in adipose tissue of obese humans, ATGL gene
expression (81) or protein content (114) was comparable to
nonobese subjects. Furthermore, in insulin-resistant subjects,
adipose tissue ATGL mRNA levels were lower compared with
obese subjects with preserved insulin sensitivity irrespective of
body fat mass or fat distribution (9).
In insulin-resistant subjects, weight loss resulted in a de-
crease in ATGL and HSL mRNA- and protein level (61), but
in insulin-nonresistant subjects, this decrease was not detected
(81). However, the insulin-resistant subjects were studied in
negative energy balance, whereas the insulin-nonresistant sub-
jects were studied after energy balance was restored (81). In
normoglycemic young men, exercise training resulted in in-
creased ATGL protein in muscle without changes in HSL
protein level, but with a decline in muscle TAG content (4).
Strikingly, exercise training in general improves insulin sensi-
tivity, whereas the changes observed here could imply in-
creased DAG levels, which is supposed to impede insulin
sensitivity. Unfortunately data on DAG or insulin sensitivity
have not been reported in this study.
ATGL activity requires coactivation by comparative gene
identification-58 (CGI-58), also known as /-hydrolase do-
main containing 5 (ABHD5) (74, 120, 160). CGI-58 stimulates
TAG hydrolysis in wild-type and HSL-deficient adipose tissue
but fails to activate lipolysis in the absence of ATGL, suggest-
ing that CGI-58 is not a lipase as such, but rather facilitates
lipolysis by ATGL but not HSL (120). ATGL activity was
enhanced 20-fold in the presence of CGI-58 (74). Furthermore,
a mutation in CGI-58 is associated with Chanarin-Dorfman
Syndrome, a rare genetic disease resulting in excessive ectopic
TAG accumulation. Reintroduction of functional CGI-58 nor-
malizes the TAG content in peripheral tissues of these patients
(74). These results indicate that CGI-58 is required to maxi-
mize the rate of TAG hydrolysis. Regulation of ATGL activity
by CGI-58 requires interaction with lipid droplet-coating pro-
teins of the PAT family, which will be discussed in Lipid
droplet-binding proteins not related to the PAT family.
Several studies have provided evidence that ATGL and HSL
act coordinately in hydrolyzing triglycerides (73). The current
hypothesis states that ATGL hydrolyzes the first ester bond of
the TAG molecule, whereas HSL preferentially degrades DAG
(36, 120). Data indicate that this is the case for TAG stored in
adipose tissue, as well as for TAG stored ectopically. A
disequilibrium in ATGL and HSL activation in insulin-respon-
sive tissues like muscle may increase the content of the
insulin-desensitizing lipid intermediate DAG. So far, however,
this putative disequilibrium has not been reported in muscle of
type 2 diabetic subjects.
MGL and other lipases. Information on the role and regu-
lation of monoacylglycerol lipase (MGL) is limited, especially
for ectopically stored fat. Given the specific affinity of ATGL
for TAG and of HSL for DAG, another lipase with a high
affinity for MAG hydrolysis could be of importance in adipose
tissue and skeletal muscle. In adipose tissue, it has, indeed,
been shown that MGL is of importance for complete hydrolysis
of MAG (37). Experiments in murine white adipose tissue in
vitro to examine the relative contribution of ATGL and HSL to
total lipolysis revealed that joint action of ATGL and HSL is
responsible for 95% of total hydrolytic activity (120), suggest-
ing a quantitatively minor role for other lipases, including
MGL.
Triacylglycerol hydrolase (TGH) and triacylglycerol hydro-
lase homologue (TGH-2) are TAG-specific lipolytic enzymes
highly expressed in liver and adipose tissue (98). In contrast to
ATGL and HSL, TGH and TGH-2 efficiently hydrolyze triac-
ylglycerol comprising short-chain fatty acids. Because of he-
patic conversion of short-chain fatty acids into long-chain fatty
acids by elongases and the absence in muscle of a short-chain
fatty-acid specific synthase, the vast majority of the TAG
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stored in the human body comprises long-chain fatty acids.
Whereas the quantitative role of TGH and TGH-2 in hydrolysis
of hepatic TAG may be highly relevant, its role in hydrolysis
of myocellular TAG may be less prominent.
Jointly, ATGL and HSL can hydrolyze the vast majority of
the TAG in adipose tissue and skeletal muscle; at present, there
is little reason, suggesting that defects in hydrolysis of MAG in
skeletal muscle can play a major role in modulating lipid-
desensitizing intermediates in skeletal muscle.
Lipid Droplet-Coating Proteins
The LD is coated by a phospholipid monolayer decorated
with a family of proteins, referred to as PAT proteins, charac-
terized by a common NH2-terminal motif. PAT refers to
perilipin, ADRP, and TIP47, but the PAT family also com-
prises S3-12 and OXPAT, two proteins with sequence homol-
ogy and/or similar function as the originally identified PAT
proteins. Each of these PAT proteins has a unique tissue
distribution and lipid-binding properties. In addition, all PAT
proteins identified so far can localize to LD, whereas TIP47 are
also present in other subcellular compartments. Thus, it is
likely that the different PAT proteins may have (at least partly)
distinct roles in TAG management.
Perilipin. In adipose tissue, activation of perilipin by phos-
phorylation is required for full activation of HSL-related hy-
drolysis. Perilipin is the predominant PAT protein in adipose
tissue involved in control of storage and degradation of lipid
stored in the LD (1, 39, 125, 126). Expression of perilipin is
under control of the transcription factor PPAR (1, 6, 26), and
perilipin is predominantly found on the LD of adipose tissue
(10, 43, 103). In the fed state and in the presence of insulin,
perilipin is not phosphorylated on PKA site serines and coats
the LD in adipose tissue (32, 89), thereby limiting lipolytic
activity of HSL to lipid stored in the LD (15, 88). In contrast,
under lipolytic conditions, perilipin gets phosphorylated by
PKA (15, 43, 44), allowing HSL to access the LD (88, 91, 126,
132, 133). In line with this, TAG levels in adipose tissue of
perilipin knockout mice (83, 133) and in cells lacking perilipin
is reduced (15, 83, 88), suggesting a pivotal role for perilipin in
regulating HSL activity. Despite higher lean body mass and an
increased metabolic rate, perilipin-null mice tend to develop
glucose intolerance and peripheral insulin resistance (115).
Interestingly, perilipin levels in adipose tissue from obese
Zucker rats and obese humans appear lower than in lean
controls if matched for fat cell mass (26, 91, 144). It is
important to note that most of the data on regulation of lipolyis
of lipid stored in LD and of interaction of perilipin with HSL
has been published in the pre-ATGL era, and hence, one cannot
exclude the possibility that some of these observations have
been confounded by lipase activity of ATGL, which by then,
was not yet discovered.
Although hydrolysis of TAG in myocellular LD involves
HSL activity, skeletal muscle is devoid of perilipin. Rather,
adrenaline and contractile activity-associated increases in TAG
hydrolysis in myocellular LD goes along with recruitment of
HSL to ADRP and TIP-47-coated LD (105), suggesting that
these PAT proteins may be myocellular analogs of perilipin
that operate in muscle to control basal and stimulated lipolysis.
ADRP. Shortly after the discovery of perilipin, adipose
differentiation-related protein (ADRP) was identified (34, 59).
ADRP is expressed in a wider range of tissues than perilipin
(13, 50), including rodent and human skeletal muscle (103,
105). ADRP is involved in the uptake of long-chain fatty acids
from the cytoplasm and incorporation of fatty acids in LD (20,
38, 76, 80, 85). In livers from ob/ob mice (116) and etomoxir
(i.e., CPT-1 inhibitor)-treated rats (128) and in specific dis-
eases states involving ectopic fat accumulation (50, 90), ADRP
expression is increased.
Like perilipin, ADRP decorates the LD membrane, thus
affecting lipolytic activity of ATGL and recruitment of another
PAT protein, TIP47, to the lipid droplet (76, 97). In ADRP-
expressing tissues, hydrolysis of TAG in LD might indeed be
under control of ADRP (105, 150). Tissue-specific and whole
body knockout studies of ADRP resulted in resistance to
diet-induced hepatic steatosis, while adipocyte differentiation
and lipolysis were unaffected (20). The absence of changes in
adipogenesis may originate from a compensatory induction of
TIP47. In ADRP knockout cells with concomitant siRNA-
mediated downregulation of TIP47, LD formation was atten-
uated, and fatty acids added to the system incorporated into
phospholipids in cellular membranes other than LD (131).
Downregulation of hepatic ADRP using antisense oligonucle-
otides reduced hepatic steatosis, hypertriglyceridemia, and in-
sulin resistance in obese mice (55) and rescued diet-induced
obese mice from developing insulin resistance. These favor-
able effects were attributed to lower levels of the insulin-
desensitizing lipid intermediate DAG in the livers of the treated
animals (140).
ADRP may also be involved in regulating subcellular local-
ization of the LD. In preadipocytes, ADRP associates with the
intermediate filament protein vimentin (10, 43, 103), suggest-
ing that intracellular trafficking of the lipid droplets may occur.
This notion was substantiated by the observation that the
microtubular motor protein dynein—allowing the droplet to
move within the cell along the microtubular system—copre-
cipitated with ADRP (12). Extending these observations to
skeletal muscle is intriguing; in mature skeletal muscle, LD can
be found in a highly organized manner along myofibrils and
adjacent to Z-discs (Fig. 1) in direct vicinity of the Z-disc
interconnecting intermediate filament desmin (102). The
highly organized subcellular structure of skeletal muscle is
initiated during differentiation when vimentin expression de-
creases and desmin expression increases, allowing alignment
of myofibrils in a regular array of Z-discs interconnected by
desmin (139). In this respect, it is interesting to note that in
fully differentiated skeletal muscle, the motor protein dynein
and a microtubular network machinery both are present to
traffic nascent LD from the ER toward a location in vicinity of
the Z-disc and in association with mitochondria.
In 3T3-L1 preadipocytes and in early stages of differentiat-
ing 3T3-L1 adipocytes, the gene encoding for ADRP is in-
duced, and ADRP protein content increases (13, 59). In fully
differentiated adipocytes, however, ADRP protein levels drop,
despite the persistence of high levels of ADRP mRNA. At the
protein level, it has been shown that maintenance of ADRP
content highly depends on the amount of neutral lipids present
in the cell. ADRP, which is not bound to neutral lipids, is
posttranslationally targeted for proteasomal degradation (84,
157).
Like perilipin, the ADRP promoter contains a PPAR-respon-
sive element. Likewise, ADRP gene expression can be stimu-
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lated by PPAR- (25, 27, 134) and PPAR/ ligands (21, 118).
It remains uncertain whether PPAR is also involved, since
several investigations present conflicting results (reviewed in
Ref. 27).
TIP47. Another member of the PAT protein family is the 47
kDa protein TIP47 [also known as pp17 (136)]. TIP47 is
ubiquitously expressed (26) and shares 43% homology with
ADRP (8). TIP47 gene expression is not regulated by PPAR
(26, 27). Originally, TIP47 was described to be a mannose-6-
phosphate receptor sorting device (8, 29). However, knock-
down of TIP47 had no effect on mannose-6-phosphate recep-
tors but did affect LD biogenesis, lipid incorporation, and lipid
liberation (17). Knocking-out ADRP in human hepatocytes
(Huh7) cells or in immortalized fibroblasts derived from
ADRP-ablated embryonic cells, resulted in a compensatory
increase in TIP47 (97, 131).
In contrast to ADRP, cytosolic TIP47 that is not associated
with neutral lipids is not degraded but may translocate to
nascent LD, allowing LD growth (87, 97, 153). Studies using
freeze fracture followed by Immunogold labeling revealed that
TIP47 and ADRP both are indeed extensively found in asso-
ciation with the LD membrane but may also invade the LD
(109–111). Thus, TIP47 may have a role in the packaging of
neutral lipids into droplets as well (17, 153). Exactly how
TIP47 exerts its role, especially in skeletal muscle lipid droplet
packaging, however, remains to be established.
S3-12. The PAT member family with the lowest sequence
homology to the other PAT proteins is S3-12 (117). S3-12
shares a 33-amino acid motif with ADRP and has a protein
sequence identity of 50% with both TIP47 and ADRP (79) but
does not have a PAT domain. S3-12 mRNA is induced in early
stages of adipocyte differentiation (117) and coats nascent lipid
droplets during TAG synthesis in 3T3-L1 adipocytes (151,
154). S3-12 is highly expressed in WAT and to a lesser, but
detectable, extent in BAT, cardiac and skeletal muscle (117).
Transcriptional regulation of S3-12 has been shown to be
PPAR dependent (26). So far, little information is available
on the exact role of S3-12 in muscle lipid metabolism.
OXPAT/MLDP/LSDP5. Three independent laboratories re-
cently identified a new PAT domain containing a LD-coating
protein expressed mainly in tissues with a high capacity for fat
oxidation, like (type 1) muscle fibers, cardiac muscle, brown
adipose tissue, and liver. This tissue expression profile resulted
in the protein being named OXPAT (152). The same protein
has also been identified in the myocardium and was named
myocardial lipid droplet protein (MLDP) (158), while a third
research group named the protein lipid storage droplet protein
(LSDP5) (25). Throughout this review, we will use the name
OXPAT. The primary structure of OXPAT shares a high
degree of homology to ADRP and TIP47 (25). Importantly,
OXPAT has the same PAT domain as the other PAT proteins
but has its own unique tissue expression pattern. Via mecha-
nism(s) not yet identified, OXPAT promotes both long-chain
fatty acids esterification into TAG, as well as long-chain fatty
acid oxidation (152). Because there is a significant overlap in
tissues expressing OXPAT and S3-12, it has been suggested
that OXPAT and S3-12 are coordinately and reciprocally
regulated (152). However, detailed information on the concor-
dant regulation of S3-12 and OXPAT is currently lacking.
Twelve hours of fasting increased OXPAT mRNA, and 24 h
of fasting increased OXPAT protein expression in liver and to
a lesser extent in other tissues like the heart. After 12 h of
refeeding, OXPAT mRNA levels had returned to baseline
levels (25). Interestingly, in the highly oxidative soleus muscle,
the already abundant levels of OXPAT did not respond to
fasting or refeeding. Activation of PPAR induced OXPAT
expression in wild-type mice but not in PPAR knockout mice,
suggesting that the presence of PPAR is required for induc-
tion of the OXPAT gene. Fasting increased OXPAT mRNA
levels in wild-type mice, but for reasons not yet understood,
Fig. 1. Lipid droplets in skeletal muscle are deposited in a highly organized manner, revealing a string of punctate red lipid droplets if examined in Oil red
O-stained sections imaged by fluorescence microscopy (A). If examined using WETSEM technology imaged by low-power electron microscopy (137), lipid
droplets appear in strings of punctate white lipid droplets (B). In glutaraldehyde fixed, osmium tetroxide postfixed, and uranylacetate-stained ultra-thin sections
examined in transmission electron microscopy, lipid droplets can be observed adjacent to Z-discs and mitochondria in skeletal muscle (C).
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also in the PPAR knockout animals. It should be noted,
though, that because of a considerably lower baseline expres-
sion of OXPAT in the PPAR knockout mice, OXPAT mRNA
content, upon fasting, did not reach the levels observed in fed
wild-type mice. Thus, it can be concluded that fasting-induced
increases in OXPAT expression do not require a functional
PPAR gene, whereas functional PPAR is important for
basal expression of OXPAT in the liver and heart (25, 152,
158) Interestingly, mice and humans treated with pioglitazone
(a PPAR agonist with PPAR affinity) increased gene ex-
pression of OXPAT in adipose tissue but not in skeletal muscle
(152). Recently, we showed that in skeletal muscle from
humans that OXPAT protein content in obese control subjects
was comparable to levels found in body mass index (BMI)-
matched type 2 diabetic patients. Interestingly, we also showed
that upon rosiglitazone-induced insulin sensitization, OXPAT
levels declined significantly without changes in myocellular
LD content (86).
Lipid droplet-binding proteins not related to the PAT family.
Full activation of ATGL requires interaction of a coactivator
known as CGI-58, which, in turn, interacts with perilipin and
ADRP on the surface of LD in 3T3-L1 cells (41, 130, 159–
161). It has been hypothesized that physical association of
ATGL with CGI-58 requires release of CGI-58 from the
(adipocyte) droplet to exert full lipolytic activity of ATGL
(130, 160). Experimental data in 3T3-L1 adipocytes indicate
that in the basal condition, CGI-58 strongly interacts with
perilipin. Upon phosphorylation of perilipin, CGI-58 detaches
from perilipin and is released from the droplet to translocate
and interact with ATGL at the surface of small LD at sites
devoid of perilipin (41).
Given the ubiquitous expression of CGI-58 and the multiple
tissues expressing ATGL, it is likely that activation of TG
hydrolysis by ATGL and its coactivation by CGI-58 is not
restricted to adipose tissue, but it is also operational in, for
example, cardiac and skeletal muscle. The notion that CGI-58
might also be operational in skeletal muscle is substantiated by
the observations that patients suffering from mutations in either
the CGI-58 gene or in the ATGL gene present with severe
muscle weakness and myopathies (3, 66). As perilipin is not
present in muscle tissue, coregulation of ATGL by CGI-58 in
skeletal muscle most likely involves other (PAT) protein(s).
Indeed, it has recently been shown in mouse cardiac myocytes
that in virtually all OXPAT-containing LD also, CGI-58 was
detected. In LD, mainly coated by ADRP, no such interac-
tion was observed. Loading cardiac myocytes with oleate
promoted interaction of OXPAT with CGI-58 and appeared
critical in regulating ATGL lipolytic activity in OXPAT
containing LD (42).
By detailed examination of multiple proteins undergoing
major changes in expression during adipogenesis, two mem-
bers of the Cide domain-coating proteins, CideA and CideC
(also known as fat-specific protein 27, FSP27), have recently
been identified as LD-binding proteins (62, 95, 106, 107, 138).
These proteins appear to be involved in the negative regulation
of lipolysis and, hence, in LD morphology and LD dynamics in
a perilipin-like manner (106). Ectopically overexpressed CideC
colocalizes to perilipin (106), suggesting interaction of both pro-
teins in facilitating LD lipolysis.
CideA is predominantly expressed in BAT, with small
amounts of mRNA detected in among others cardiac and
skeletal muscle. CideC is more widespread, with high levels in
WAT and moderate levels in BAT and skeletal muscle (155).
Overexpression of CideA and CideC blunts lipid droplet deg-
radation and results in increased ectopic fat storage (106).
Downregulation of CideA using RNAi markedly elevates li-
polysis in human adipocytes (107). Transcriptional rate of both
CideA and CideC is controlled by PPAR. Hence, treating
mice with rosiglitazone induced CideA gene expression and
lipid deposition in WAT (107). In humans, expression of
CideA and CideC correlates positively with insulin sensitivity.
A third member of this family, Cide B appears to be involved
in hepatic fat storage. Indeed, Cide B knockout mice possessed
reduced high-fat diet-induced hepatic steatosis and lower cir-
culatory plasma TGs, and they were insulin sensitive (75).
In search for binding proteins to pigment epithelium-derived
factors (PEDF), Notari et al. (96) serendipitously identified
ATGL as a PEDF binding protein, where ATGL exerts lipase
activity to phospholipids (96). Interestingly, PEDF coprecipi-
tates with ATGL in hepatocytes (22), and the lack of PEDF
with subsequent reintroduction was associated with significant
increases in steatosis and normalization toward control values,
respectively (22). Thus, via binding to ATGL, PEDF may have
a role in hepatic triglyceride homeostasis, and, hence, insulin
sensitivity. Indeed, it has recently been shown that adminis-
trating PEDF to mice stimulated adipose tissue lipolysis, aug-
mented ectopic lipid deposition, and reduced insulin sensitiv-
ity. On the other hand, antibody-based neutralization of PEDF
in obese mice enhanced insulin sensitivity (24). Overall, these
results identify a causal role for PEDF in obesity-induced
insulin resistance.
At this stage, it seems safe to conclude that next to the PAT
proteins, other proteins with a role in LD dynamics start to
emerge. It is, however, not yet fully understood how these
proteins may interact to exert their role in modulation of LD
dynamics.
Lipid Droplet Formation
Information on formation, maturation, and potential traffick-
ing of LD in different cell types or tissues is still fragmentary
and not always consistent. As reviewed by several authors (16,
82, 92, 93, 150), it has been hypothesized that neutral lipids are
deposited between the leaflets of the ER membrane and then
budded into the cytoplasm to form a primordial LD. LD-
coating proteins might be either integral ER membrane pro-
teins or may be added to the growing LD from the cytosol.
Proteins coating the LD may originate from proteins resident in
the cytoplasmic leaflet of ER membranes (16, 99). In contrast
it has been shown that the fatty acid composition of LD
phospholipids differed from that of rough ER phospholipids
(135), reducing the likeliness that these droplets indeed origi-
nally budded from the ER. Alternatively, LD may be formed at
specialized ADRP-enriched domains on the cytoplasmic sur-
face of the ER (108).
At present, none of the existing models fully explains how
TAG is incorporated into ER-associated LD.
Lipid droplet growth. Upon formation, LD continue to grow
until they reach their mature size and the amount of TAG in the
LD increases. The rate-limiting enzyme in TAG synthesis is
diacylglycerol acyl-transferase (DGAT), which converts DAG
into TAG. Hence, the involvement of DGAT in TAG accretion
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in the LD and increased LD size is anticipated (see Fig. 2).
DGAT is present in two isoforms. DGAT1 and DGAT2 both
have been located to the ER, albeit at distinct regions (18, 19).
Fluorescence microscopy of polyene-labeled lipids revealed
the presence of DAG to the outside of LD in COS7 cells (70).
It has been shown that DGAT2 localizes to the ER under basal
conditions and was targeted to the surface of LD in COS7 cells
upon oleate loading (129) and that endogenous DGAT2 was
localized to the vicinity of LD in 3T3-L1 adipocytes (70). This
model is compatible with the origin of LD from the ER and
demonstrates that LD can grow in size by inflow of TAG
synthesized by DGAT2. Whether DGAT2 and DAG also
localize to the LD in other cell types than fibroblasts and
adipocytes and how newly formed TAG enters the lipid droplet
is not yet known.
Recently, Olofsson et al. (11) hypothesized that primordial
droplets are trafficking in the cytosol and fuse in vicinity of
other LD (11). Fusion of LD requires membrane fusion of the
lipid droplet-coating phospholipid monolayers, in a process
facilitated by SNAP23 (11). Physical interaction of myocellu-
lar LD under TAG-storing conditions (DGAT 1 overexpression
combined with a high-fat diet) is shown in Fig. 2B. Interest-
ingly, fusion of GLUT4-containing vesicles with the sarco-
lemma upon insulin stimulation also requires SNAP23 [for
review, see Huang and Czech (53)]. Increasing the amount of
SNAP23 to the membrane of LD upon oleate loading resulted
in reduced GLUT4 fusion with the sarcolemma, possibly due
to the low levels of SNAP remaining for GLUT4 membrane
fusion (11). In line with this, overexpressing SNAP23 rescued
oleate-mediated insulin resistance (11).
Involvement of PAT proteins in trafficking of LD has been
hypothesized and partly been proven by Wolins et al. (150). In
his model, PAT proteins are classified on the basis of their
stability if not bound to neutral lipids (150). Perilipin and
ADRP can be classified as proteins requiring neutral lipids to
maintain stability in the absence of neutral lipids. Perilipin and
ADRP are degraded via the ubiquitin/proteasome (156, 157).
Tip47, S3-12, and OXPAT, on the other hand, are situated in
the cytosolic pool under nonlipid-loading conditions and
may translocate to nascent LD upon lipid loading (150). In
line with this, in 3T3-L1 cells incubated with long-chain
fatty acids, TAG-filled droplets coated with TIP47, S3-12,
and ADRP appear. Subsequently, S3-12 and TIP47 coat the
smallest and most peripheral LD, whereas ADRP coats a more
medial population of larger LD (151, 154), and the largest
droplets are coated with perilipin. Although part of this hy-
pothesis has been confirmed in adipocytes, it should be noted
that only adipocytes express all five members of the PAT
family at significant levels. Most other cell types express two,
or at most three PAT proteins.
Lipid Droplet Dynamics and Insulin Resistance
Obviously, tight interaction of PAT proteins and well-bal-
anced activity of lipases is required to effectively store fatty
acids in LD in times of lipid overflow and for controlled release
of fatty acids in times of enhanced demand. Dysregulation of
any of these processes might lead to disturbed LD synthesis
and/or LD degradation, resulting in a rise in insulin-desensi-
tizing intermediates. It is, therefore, of importance to improve
our understanding of regulation of lipid synthesis and degra-
dation in ectopically stored LD and the proteins involved. This
type of information in humans, and especially in patient pop-
ulations, is largely lacking and mainly associative. For exam-
ple, lower perilipin protein levels have been reported in adi-
pose tissue from obese vs. lean women (91, 144). Another
study investigated the relation between ADRP and insulin
sensitivity in skeletal muscle after a weight loss intervention
program and after a pharmacological intervention program
with troglitazone (103). Although a correlation between ADRP
and insulin sensitivity was not detectable at baseline, ADRP in
skeletal muscle was significantly increased after treatment and
correlated with improved insulin sensitivity (103). Further-
more, a population of 85 nondiabetic subjects with a wide
range of BMI and insulin sensitivity was investigated, and a
negative correlation between OXPAT gene expression in adi-
Fig. 2. Transmission electron microscopy image of glutaraldehyde-fixed,
osmium tetroxide postfixed, epon-embedded, and uranylacetate-stained ultra-
thin section of muscle overexpressing diacylglycerol acyl-transferase 1, along
with consumption of a high-fat diet (113). This model resulted in large lipid
droplets (LD) scattered throughout the muscle cell (A), and some LD appear
physically very close or even interconnected, creating the physical condition
for LD fusion (B).
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pose tissue and BMI was found (152). From these data, cause
and consequence cannot be separated, and other processes,
which were not examined, may also contribute to, or even
cause, the observed correlation between OXPAT and BMI
(152).
Perspective and Significance
For decades, intracellular lipid droplets (LD) in nonadipose
tissue have been considered to be relatively inert sites of fat
storage, which are well preserved across species and can be
found in a wide variety of sizes and quantities in various
tissues. In lipid bodies in adipocytes, however, it has been
recognized that synthesis and degradation of lipid in LD are
fairly dynamic processes. Predominantly arising from reports
in adipocytes and progress in the imaging of lipid droplets in
live cells, the body of knowledge on LD dynamics and the
proteins involved have rapidly expanded recently. Defects in
LD dynamics have been linked to multiple disorders in lipid
and lipoprotein metabolism and may contribute to the insulin-
desensitizing effects of lipid intermediates (partly originating
from LD), in insulin-responsive tissues like adipose tissue,
liver, and cardiac and skeletal muscle.
Hydrolysis of lipid stored in LD is catalyzed by the con-
certed action of distinct lipases, which differ in their affinity for
triacyl-, diacyl- or monoacylglycerol. In muscle, the two most
abundant and best described lipases identified so far are HSL
and ATGL. These lipases regulate—both positively and neg-
atively—the rate of lipolysis by tight cooperation with a family
of structurally related lipid droplet-coating proteins (perilipin,
ADRP, TIP47, S3-12, and OXPAT, collectively referred to as
PAT proteins) and with coactivators like CGI-58. While ex-
pression of perilipin appears to be restricted to adipose tissue,
the other PAT proteins can be found in other cell types as well.
Adrenergic stimulated lipolysis in adipose tissues results in
PKA-mediated phosphorylation of perilipin, which recruits
HSL to the LD surface to stimulate lipolysis. In addition, PKA
activation results in dissociation of CGI-58 from the LD in a
perilipin-dependent manner, allowing ATGL-based lipolysis.
Prolonged PKA-mediated lipolysis results in smaller LD dec-
orated with ADRP, TIP47, and S3-12.
While interaction of CGI-58 with ADRP has been described
as well, it remains unclear whether and in which tissues this
interaction affects lipolytic rate. In muscle, interaction of
OXPAT with CGI-58 appears to be critical in regulating
lipolytic activity of ATGL, but more work is needed to test to
what extent information derived from other tissues or cell types
can be translated toward (human) skeletal muscle.
Our knowledge on involvement of PAT proteins and their
putative interaction with lipases in the regulation of lipolysis of
lipid droplets has rapidly expanded. In addition, the emerging
body of knowledge from cell studies toward LD growth and
fusion expands the field to further explore the mechanisms
involved in (dys)regulation of LD dynamics in ectopically
stored fat in insulin-responsive tissues like liver and (skeletal)
muscle. With this area of research developing, targets to
modulate ectopic fat storage, in terms of synthesis, degrada-
tion, and lipid turnover, may be identified in the near future that
may shed new light on routes to rescue myocellular insulin
resistance, the hallmark in the development of overt type 2
diabetes.
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